CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 92 enrolled
Drug / intervention
Early CCLADbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04736316
NCT04736316N/ACompleted
CompareCT.gov

Early Community Client-Led ART Delivery (CCLAD) to Optimize HIV Care Engagement in Nakivale Refugee Settlement

University of Washington·interventional·Posted Feb 3, 2021·Updated Jul 11, 2023

In Brief

A clinical study evaluating Early CCLAD for HIV Seropositivity. Completed, enrolled 92 participants across 1 site.

Detailed Summary

To pilot early community client-led ART (anti-retroviral therapy) delivery (CCLAD) in Nakivale Refugee Settlement in Uganda and assess the feasibility and acceptability of this intervention in this setting.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Seropositivity
CountriesUganda
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 3, 2021
Enrollment StartJun 29, 2020
Primary CompletionMar 31, 2022
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 5.4 years ago

Interventions

Early CCLADbehavioral

Community-based client led antiretroviral therapy delivery groups.